These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 8148348)

  • 1. ApoB metabolism in familial hypercholesterolemia. Inconsistencies with the LDL receptor paradigm.
    Fisher WR; Zech LA; Stacpoole PW
    Arterioscler Thromb; 1994 Apr; 14(4):501-10. PubMed ID: 8148348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VLDL and IDL apolipoprotein B-100 kinetics in familial hypercholesterolemia due to impaired LDL receptor function or to defective apolipoprotein B-100.
    Zulewski H; Ninnis R; Miserez AR; Baumstark MW; Keller U
    J Lipid Res; 1998 Feb; 39(2):380-7. PubMed ID: 9507998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic pathways of apolipoprotein B in heterozygous familial hypercholesterolemia: studies with a [3H]leucine tracer.
    Fisher WR; Zech LA; Kilgore LL; Stacpoole PW
    J Lipid Res; 1991 Nov; 32(11):1823-36. PubMed ID: 1770302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The magnitude of decrease in hepatic very low density lipoprotein apolipoprotein B secretion is determined by the extent of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition in miniature pigs.
    Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Newton RS; Huff MW
    Endocrinology; 1999 Nov; 140(11):5293-302. PubMed ID: 10537160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of apolipoprotein B metabolism in familial defective apolipoprotein B and heterogeneous familial hypercholesterolemia.
    Gaffney D; Forster L; Caslake MJ; Bedford D; Stewart JP; Stewart G; Wieringa G; Dominiczak M; Miller JP; Packard CJ
    Atherosclerosis; 2002 May; 162(1):33-43. PubMed ID: 11947895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of apolipoprotein B secretion in hepatocytes from Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia.
    Tanaka M; Otani H; Yokode M; Kita T
    Atherosclerosis; 1995 Apr; 114(1):73-82. PubMed ID: 7605378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of atorvastatin and simvastatin on apolipoprotein B metabolism in moderate combined hyperlipidemic subjects with low VLDL and LDL fractional clearance rates.
    Forster LF; Stewart G; Bedford D; Stewart JP; Rogers E; Shepherd J; Packard CJ; Caslake MJ
    Atherosclerosis; 2002 Sep; 164(1):129-45. PubMed ID: 12119202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic basis of hyperapobetalipoproteinemia. Turnover of apolipoprotein B in low density lipoprotein and its precursors and subfractions compared with normal and familial hypercholesterolemia.
    Teng B; Sniderman AD; Soutar AK; Thompson GR
    J Clin Invest; 1986 Mar; 77(3):663-72. PubMed ID: 3949973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of HMG-CoA reductase by atorvastatin decreases both VLDL and LDL apolipoprotein B production in miniature pigs.
    Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Newton RS; Huff MW
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2589-600. PubMed ID: 9409231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormalities in metabolism of low density lipoproteins associated with coronary heart disease.
    Grundy SM; Vega GL; Kesäniemi YA
    Acta Med Scand Suppl; 1985; 701():23-37. PubMed ID: 3907293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased hepatic secretion of very-low-density-lipoprotein apolipoprotein B-100 in heterozygous familial hypercholesterolaemia: a stable isotope study.
    Cummings MH; Watts GF; Umpleby M; Hennessy TR; Quiney JR; Sönksen PH
    Atherosclerosis; 1995 Feb; 113(1):79-89. PubMed ID: 7755658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nutritional regulation of cholesterol synthesis and apolipoprotein B kinetics: studies in patients with familial hypercholesterolemia and normal subjects treated with a high carbohydrate, low fat diet.
    Stacpoole PW; von Bergmann K; Kilgore LL; Zech LA; Fisher WR
    J Lipid Res; 1991 Nov; 32(11):1837-48. PubMed ID: 1770303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shifting the LDL-receptor paradigm in familial hypercholesterolemia: novel insights from recent kinetic studies of apolipoprotein B-100 metabolism.
    Barrett PH; Watts GF
    Atheroscler Suppl; 2002 Mar; 2(3):1-4. PubMed ID: 11923121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complete deficiency of the low-density lipoprotein receptor is associated with increased apolipoprotein B-100 production.
    Millar JS; Maugeais C; Ikewaki K; Kolansky DM; Barrett PH; Budreck EC; Boston RC; Tada N; Mochizuki S; Defesche JC; Wilson JM; Rader DJ
    Arterioscler Thromb Vasc Biol; 2005 Mar; 25(3):560-5. PubMed ID: 15637307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased production of VLDL apoB-100 in subjects with familial hypercholesterolemia carrying the same null LDL receptor gene mutation.
    Tremblay AJ; Lamarche B; Ruel IL; Hogue JC; Bergeron J; Gagné C; Couture P
    J Lipid Res; 2004 May; 45(5):866-72. PubMed ID: 14967814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E.
    Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
    Biochim Biophys Acta; 2000 Feb; 1484(1):29-40. PubMed ID: 10685028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired receptor-mediated catabolism of low density lipoprotein in the WHHL rabbit, an animal model of familial hypercholesterolemia.
    Bilheimer DW; Watanabe Y; Kita T
    Proc Natl Acad Sci U S A; 1982 May; 79(10):3305-9. PubMed ID: 6285345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-density lipoprotein receptor binding determinants switch from apolipoprotein E to apolipoprotein B during conversion of hypertriglyceridemic very-low-density lipoprotein to low-density lipoproteins.
    Bradley WA; Hwang SL; Karlin JB; Lin AH; Prasad SC; Gotto AM; Gianturco SH
    J Biol Chem; 1984 Dec; 259(23):14728-35. PubMed ID: 6501314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physiologic mechanisms of action of lovastatin in nephrotic syndrome.
    Aguilar-Salinas CA; Barrett PH; Kelber J; Delmez J; Schonfeld G
    J Lipid Res; 1995 Jan; 36(1):188-99. PubMed ID: 7706943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of cholesteryl ester synthesis in mouse peritoneal macrophages by cholesterol-rich very low density lipoproteins from the Watanabe heritable hyperlipidemic rabbit, an animal model of familial hypercholesterolemia.
    Kita T; Yokode M; Watanabe Y; Narumiya S; Kawai C
    J Clin Invest; 1986 May; 77(5):1460-5. PubMed ID: 3700648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.